A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Inflammation in the brain plays a major role in neurodegenerative diseases. In particular, microglial cell activation is believed to be associated with the pathogenesis of neurodegenerative diseases, including Parkinson's disease (PD). An increase in microglia activation has been shown in the substantia nigra pars compacta (SNpc) of PD models when there has been a decrease in tyrosine hydroxylase (TH) positive cells. This may be a sign of neurotoxicity due to prolonged activation of microglia in both early and late stages of disease progression. Natural products, such as spirulina, derived from blue green algae, are believed to help reverse this effect due to its anti-inflammatory/anti-oxidant properties. An adeno-associated virus vector (AAV9) for α-synuclein was injected in the substantia nigra of rats to model Parkinson's disease and to study the effects of spirulina on the inflammatory response. One month prior to surgeries, rats were fed either a diet enhanced with spirulina or a control diet. Immunohistochemistry was analyzed with unbiased stereological methods to quantify lesion size and microglial activation. As hypothesized, spirulina was neuroprotective in this α-synuclein model of PD as more TH+ and NeuN+ cells were observed; spirulina concomitantly decreased the numbers of activated microglial cells as determined by MHCII expression. This decrease in microglia activation may have been due, in part, to the effect of spirulina to increase expression of the fractalkine receptor (CX3CR1) on microglia. With this study we hypothesize that α-synuclein neurotoxicity is mediated, at least in part, via an interaction with microglia. We observed a decrease in activated microglia in the rats that received a spirulina- enhanced diet concomitant to neuroprotection. The increase in CX3CR1 in the groups that received spirulina, suggests a potential mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Effect of spirulina on TH immunoreactive cells in the SNpc. TH positive cells in the SNpc after 1 or 4 months of α-synuclein expression. Cells were counted using unbiased stereological counting techniques. (A) One month after α-synuclein gene transfer, there was a significant decrease in TH positive cells as compared to GFP control (N = 12–18/group). The spirulina diet group lesioned with α-synuclein (N = 12) had greater numbers of TH positive cells compared to the control diet group lesioned with α-synuclein (N = 18). There was a diet by vector group interaction in the two way ANOVA analysis [F = 5.569, p<0.01]. (B) Results at four months were similar. There was a similar loss of TH positive cells and protective effect of spirulina. Two-way ANOVA yielded a main effect of diet (F = 81.3), and a main effect of vector group (F = 45.5; p<0.01), although without a significant interaction. Bonferonni post-hoc tests comparing NIH 31 GFP (N = 10) vs NIH 31 synuclein (N = 8) and NIH31 synuclein vs spirulina synuclein (N = 8) groups were significant). Asterisk denotes significance (*P<0.05; **p<0.01).](https://figures.cochat.ai/paper-figures/2819f8272f0842d2904977d041ee6d23/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-1.jpg)
![Figure 2 Effect of spirulina on NeuN immunoreactive cells in the SNpc. NeuN positive cells in the SNpc after 1 or 4 months of α-synuclein expression. At 1 month, there was a decrease in NeuN positive cells in the SN, mirroring the loss of TH positive cells in Fig. 1. This confirms cell loss rather than loss of TH expression. The effect was similar at 4 months of expression (B). There was neuroprotection in the groups that received a diet enhanced with spirulina at both intervals. Two-way ANOVA yielded a significant interaction of diet and vector treatment at both time points [1 month F = 6.931, df = 1; 4 months F = 8.899 df = 1]. (*p<0.05; **p<0.01) after Bonferonni's post-hoc.](https://figures.cochat.ai/paper-figures/1f2c1055f07f4a719d00e0681c242475/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-2.jpg)
![Figure 3 Effect of spirulina on OX-6 positive staining. There was a decrease in OX-6 positive staining in the groups that received spirulina at both 1 (A) and 4 (B) months of α-synuclein expression as compared to the control groups. Two-way ANOVA was performed for both 1 and 4 month groups and showed a significant interaction between diet and vector treatment [1 month F = 5.592, df = 1] and [4 months F = 8.899, df = 1]. Bonferonni post hoc analysis for individual comparisons is shown (*p<0.05, and ***p<0.001).](https://figures.cochat.ai/paper-figures/3e37267e588c4a6e83fd30446ec7c9ee/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some authors have reported that Arthrospira platensis supports the resistance to the oxidative aspect of microglial cell activity and fights against memory loss [92,93].”
From Application of Arthrospira platensis for Medicinal Purposes and the Food Industry: A Review of the Literature (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and activation of microglial cells is thought to be involved in the pathogenesis of neurodegenerative diseases [88].”
From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“In some forms of familial PD the asynuclein gene is triplicated or carries a missense mutation [10,11,11–13].”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 3×
“CX3CR1 is a chemokine receptor that when stimulated, leads to reduced synthesis of pro-inflammatory cytokines IL1b and TNFa [29].”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“CX3CL1 and CX3CR1 are normally expressed at relatively high levels in the brain [29,40] but decrease during aging, and may be involved in neurodegenerative diseases [29].”
BackgroundClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 1×
“Since its discovery in 2004 by Gao and colleagues [25], the AAV9 vector variant has proven to be efficient for neuronal gene transfer [26,27].”
BackgroundKirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649 · cited 1×
“AAV vector gene transfer of a-synuclein has established a progressive loss of DA neurons in the SN [12,24] that may be more relevant to PD pathogenesis than more rapid neurotoxin models.”
BackgroundSynuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 1×
“was observed [30].”
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · cited 1×
“An increase in numbers of microglia and the presence of activated microglia has been noted in several studies and they are present in both early and late stages of the disease [4–6].”
Background
Cited by
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview
Wu, Q., Liu, L., Miron, A., Klímová, B., Wan, D., & Kuča, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1744-5 · Cited by 655
The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
Sanchez-Guajardo, V., Tentillier, N., & Romero-Ramos, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.008 · Cited by 172
Furmaniak, M. A., Misztak, A. E., Franczuk, M. D., Wilmotte, A., Waleron, M., & Waleron, K. F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02541 · Cited by 121
“Another animal study demonstrates “Spirulina”’s ability to protect neurons in the αsynuclein model of Parkinson Disease (Pabon et al., 2012).”
BackgroundFractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2015) · Molecular Therapy · doi:10.1038/mt.2014.175 · Cited by 108
“Surgery was performed as described previously [33, 49].”
MethodSelf-citationGentscheva, G., Nikolova, K., Panayotova, V., Peycheva, K., Makedonski, L., Slavov, P., Radusheva, P., Petrova, P., & Yotkovska, I. (2023) · Life · doi:10.3390/life13030845 · Cited by 106
Beneficial Effects of Spirulina Consumption on Brain Health
Trotta, T., Porro, C., Cianciulli, A., & Panaro, M. A. (2022) · Nutrients · doi:10.3390/nu14030676 · Cited by 98
“Spirulina/Orally Male Fisher 344 rats treated with α-Syn in substantia nigra Reduction in the number of activated microglial cell [88] Increased expression of the fractalkine receptor (CX3CR1) on microglia”
BackgroundWide range applications of spirulina: from earth to space missions
Fais, G., Manca, A., Bolognesi, F., Borselli, M., Concas, A., Busutti, M., Broggi, G., Sanna, P., Castillo-Aleman, Y. M., Rivero-Jiménez, R. A., et al. (2022) · Marine Drugs · doi:10.3390/md20050299 · Cited by 98
Mähler, A., Mandel, S. A., Lorenz, M., Rüegg, U. T., Wanker, E. E., Boschmann, M., & Paul, F. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-5 · Cited by 104
Spirulina Microalgae and Brain Health: A Scoping Review of Experimental and Clinical Evidence
Sorrenti, V., Castagna, D. A., Fortinguerra, S., Buriani, A., Scapagnini, G., & Willcox, D. C. (2021) · Marine Drugs · doi:10.3390/md19060293 · Cited by 88
“1% w/w Spirulina, for 30 days before and 1, 4, 16 weeks after α-synuclein treatment Tyrosin-Hydroxylase positive cells analysis, microglial activation Neuroprotection, reduction of microglial activation [51]”
BackgroundSilva, J., Alves, C., Martins, A., Susano, P., Simões, M., Guedes, M., Rehfeldt, S. C. H., Pintéus, S., Gaspar, H., Rodrigues, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041888 · Cited by 95
Shahaduzzaman, M., Nash, K., Hudson, C., Sharif, M., Grimmig, B., Lin, X., Bai, G., Liu, H., Ugen, K. E., Cao, C., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116841 · Cited by 81
Self-citationPentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
“Among these mechanisms can be mentioned oxidative stress, mitochondrial damage, neuroinflammation, endoplasmic reticulum stress, and lysosomal dysfunction, which may ultimately provoke the selective death of SNc DA neurons in PD [178, 179].”
InfluentialRecent developments in therapeutic applications of Cyanobacteria
Raja, R., Hemaiswarya, S., Ganesan, V., & Carvalho, I. S. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.957640 · Cited by 102
“A Spirulina enhanced diet provides neuroprotection in an a-synuclein model of Parkinson’s disease by reducing microglial activation through high expression of chemokine receptor, CX3CR1 (Pabon et al., 2012).”
BackgroundMitra, S., Siddiqui, W. A., & Khandelwal, S. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.06.016 · Cited by 67
Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 69
Lima, F. A. V., Joventino, I. P., Joventino, F. P., de Almeida, A. C., Neves, K. R. T., do Carmo, M. R. S., Leal, L. K. A. M., de Andrade, G. M., & Viana, G. S. D. B. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2379-5 · Cited by 69
Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease
Huang, C., Zhang, Z., & Cui, W. (2019) · Marine Drugs · doi:10.3390/md17040221 · Cited by 67
“The enhanced diet by Spirulina platensis could provide neuroprotection in α-synuclein-induced neurotoxicity model of PD [44].”
BackgroundKhalil, S. R., Khalifa, H. A., Abdel-Motal, S. M., Mohammed, H., Elewa, Y. H. A., & Mahmoud, H. A. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.03.068 · Cited by 60
McCarty, M. F., & Lerner, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103624 · Cited by 51
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Sinha, S., Patro, N., & Patro, I. K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00966 · Cited by 46
Ciccone, L., Vandooren, J., Nencetti, S., & Orlandini, E. (2021) · Pharmaceuticals · doi:10.3390/ph14020086 · Cited by 47
Chattopadhyaya, I., Gupta, S., Mohammed, A., Mushtaq, N., Chauhan, S., & Ghosh, S. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0815-0 · Cited by 42
“Similar results were found with spirulina treated on rats against the neuronal loss induced by α-synuclein [19].”
BackgroundResultSinha, S., Patro, N., & Patro, I. K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.181 · Cited by 39
McCarron, P., Logan, A. C., Giddings, S. D., & Quilliam, M. A. (2014) · Aquatic Biosystems · doi:10.1186/2046-9063-10-5 · Cited by 48
Plant-Derived Natural Products for Parkinson’s Disease Therapy
Sengupta, T. K., Vinayagam, J., Singh, R. P., Jaisankar, P., & Mohanakumar, K. P. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_23 · Cited by 45
Moradikor, N., Dadkhah, M., Ghanbari, A., Rashidipour, H., Bandegi, A. R., Barati, M., Kokhaei, P., & Rashidy‐Pour, A. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s247599 · Cited by 48
Moradikor, N., Ghanbari, A., Rashidipour, H., Yousefi, B., Bandegi, A. R., & Rashidy‐Pour, A. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.03.004 · Cited by 39
Tamtaji, O. R., Heidari‐Soureshjani, R., Asemi, Z., & Kouchaki, E. (2023) · Phytotherapy Research · doi:10.1002/ptr.7791 · Cited by 40
“, 2008), and the activation of microglial cells is thought to be involved in the pathogenesis of PD disease (Pabon et al., 2012).”
BackgroundOkamoto, T., Kawashima, H., Osada, H., Toda, E., Homma, K., Nagai, N., Imai, Y., Tsubota, K., & Ozawa, Y. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.6.20 · Cited by 37
Mousavi, M., Mehrzad, J., Najafi, M. F., Zhiani, R., & Shamsian, S. A. A. (2022) · Journal of Applied Phycology · doi:10.1007/s10811-021-02664-0 · Cited by 38
“2019), and neuroprotective (Thaakur and Sravanthi 2010; Pabon et al. 2012) properties.”
Dimopoulou, M., Kolonas, A., Stagos, D., & Gortzi, O. (2025) · Biomass · doi:10.3390/biomass5010011 · Cited by 34
Alam, M. A., Quamri, S., Fatima, S., Roqaiya, M., & Ahmad, Z. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000710 · Cited by 39
“Currently, Spirulina (a single cell filamentous algae, richest source of protein, nature best food) is documented as; antioxidant & immunomodulator [14], hepatoprotective [15], nutraceutical [16], nephroprotective [17] neuroprotective [18], cardioprotective [19], anticarcinogenic [20], anti dyslipdeamic and anti hyper…”
BackgroundNeuroprotective effect of Arthrospira(Spirulina)platensis against kainic acid-neuronal death
Pérez-Juárez, A., Chamorro, G., Alva-Sánchez, C., Paniagua-Castro, N., & Pacheco-Rosado, J. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1103756 · Cited by 33
“It has been postulated that the protective effect of SP reaches the central nervous system and could be used in the treatment of neurodegenerative diseases such as Alzheimer’s and Parkinsonism (Bermejo-Bescós et al. 2008; Pabon et al. 2012), nigrostriatal dopamine system injury (Strömberg et al.”
BackgroundSupplementation of Diets With Spirulina Influences Immune and Gut Function in Dogs
Satyaraj, E., Reynolds, A. J., Engler, R., Labuda, J., & Sun, P. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.667072 · Cited by 37
“While in a mouse model of Parkinson’s disease, a Spirulina enriched diet was found to be neuroprotective (19).”
BackgroundFajardo-Serrano, A., Rico, A. J., Roda, E., Honrubia, A., Arrieta, S., Ariznabarreta, G., Chocarro, J., Lorenzo-Ramos, E., Pejenaute, A., Vázquez, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126389 · Cited by 32
Spirulina (Arthrospira platensis): Antiallergic Agent or Hidden Allergen? A Literature Review
Gromek, W., Kołdej, N., Kurowski, M. M., & Majsiak, E. (2024) · Foods · doi:10.3390/foods13071052 · Cited by 39
Piovan, A., Battaglia, J., Filippini, R., Dalla Costa, V., Facci, L., Argentini, C., Pagetta, A., Giusti, P., & Zusso, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724993 · Cited by 31
Yang, Y., Bu, L.-L., Shen, C., Ge, J., He, S.-J., Yu, H., Tang, Y., Zhao, J., Sun, Y., Yu, W., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191909 · Cited by 32
McCarty, M. F., DiNicolantonio, J. J., & Lerner, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042140 · Cited by 29
Chen, T., Yang, F., Wong, K., Yang, Y., Li, X., Jiang, J., Wu, H., & Zheng, W. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s62530 · Cited by 26
Shahaduzzaman, M., Acosta, S., Bickford, P. C., & Borlongan, C. V. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.025 · Cited by 27
Self-citationCombination of Spirulina with glycyrrhizin prevents cognitive dysfunction in aged obese rats
Subramanian, S., & Madhavadas, S. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.150327 · Cited by 27
“[6] Anti-inflammatory and neuroprotective functions of Sp have recently been elucidated in α-synuclein models of Parkinson’s disease.[7] In another study, Gly ameliorated insulin resistance, hyperglycemia, dyslipidemia, and oxidative stress Access this article online”
BackgroundChattopadhyaya, I., Gupta, S., Asad, M., Mushtaq, N., Chauhan, S., & Ghosh, S. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0855-5 · Cited by 23
Patil, J., Matte, A., Mallard, C., & Sandberg, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1221496 · Cited by 22
Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
Grimmig, B., Morganti, J., Nash, K., & Bickford, P. (2016) · Brain Sciences · doi:10.3390/brainsci6040041 · Cited by 17
“(2011) [37] attenuated the neurotoxicity of 6 hydroxydopamine (6OHDA) by delivering a chronic intrastriatal infusion of recombinant fractalkine ligand.”
BackgroundSelf-citationThangsiri, S., Inthachat, W., Temviriyanukul, P., Sahasakul, Y., Trisonthi, P., Pan-utai, W., Siriwan, D., & Suttisansanee, U. (2024) · Scientific Reports · doi:10.1038/s41598-024-74492-4 · Cited by 24
Haider, S., Shahzad, S., Batool, Z., Sadir, S., Liaquat, L., Tabassum, S., & Perveen, T. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119417 · Cited by 20
Function of α-synuclein and PINK1 in Lewy body dementia (Review)
Minami, A., NAKANISHI, A., Matsuda, S., Kitagishi, Y., & Ogura, Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1980 · Cited by 18
“A diet with spirulina, a natural product from blue green algae, also provides neuroprotection, as demonstrated in an α -syn model of PD (64).”
Flores‐Cuadrado, A., Saiz‐Sánchez, D., Mohedano‐Moriano, A., Martínez-Marcos, A., & Úbeda‐Bañón, I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0713-7 · Cited by 16
“Neurodegeneration has been checked using NeuN labeling in different mouse PD models, including 6-OHDA injections [46], adeno-associated-virus vector (AAV9) for α-synuclein [57] and transgenic mouse overexpressing human α-synuclein under the Thy-1 promoter (Thy-α-syn) [11].”
Phycocyanin protects against Alpha-Synuclein toxicity in yeast
Macedo, D., Bertolin, T. E., Oro, T., Backes, L. T. H., Brás, I. C., dos Santos, C. N., Tenreiro, S., & Outeiro, T. F. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.044 · Cited by 16
Jung, H. Y., Kim, W., Kwon, H. J., Yoo, D. Y., Nam, S. M., Hahn, K. R., Yi, S. S., Choi, J. H., Kim, D. W., Yoon, Y. S., et al. (2020) · Marine Drugs · doi:10.3390/md18120587 · Cited by 13
Madji, S., Antih, J., Tabib, M., Silvestre, C., Ghennai, A., Warnery, A., Vaillant, F. E., Bichon, F., Echalier, A., & Poucheret, P. (2025) · Analytica—A Journal of Analytical Chemistry and Chemical Analysis · doi:10.3390/analytica6040044 · Cited by 15
Ramos, V., Reis, M. A., Ferreira, L., Silva, A. M., Ferraz, R., Vieira, M., Vasconcelos, V. M., & Martins, R. F. (2023) · Biomolecules · doi:10.3390/biom13101444 · Cited by 15
“[98]”
Abdelghany, A. K., Fouad, A. G., Abdel‐Wahab, A., Abdel‐Razik, A. H., El‐Samannoudy, S. I., Ibrahim, M. A., Hassan, W. H., & El‐Ela, F. I. A. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01301-2 · Cited by 16
“Several neuroprotective benefits of SP in various brain regions have been emphasized in numerous in vivo investigations utilizing various animal models [42, 43].”
BackgroundRetractedVirel, A., Rehnmark, A., Orädd, G., Olmedo‐Díaz, S., Faergemann, E., & Strömberg, I. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13044 · Cited by 13
“Giving a diet enriched in antioxidants to animals exposed to lesioning of the nigrostriatal dopamine system is beneficial for dopaminergic regeneration (Str€omberg et al., 2005; Pabon et al., 2012; Rehnmark & Str€omberg, 2012).”
BackgroundBeneficial Effects of Spirulina on Brain Health: A Systematic Review
Kumar, S., Saha, S., Singh, K., Singh, T., Miahra, A. K., Dubey, B. N., & Singh, S. (2024) · Current Functional Foods · doi:10.2174/0126668629269256231222092721 · Cited by 19
Mazzola, D., Fornari, F., Viganó, G. S., Oro, T., Costa, J. A. V., & Bertolin, T. E. (2015) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-89132015060216 · Cited by 12
“platensis, a cyanobacterium that contains phycocyanin, which in turn acts by promoting inactivation of free radicals (Bermejo-Bescós et al. 2008; Pabon et al. 2012; Farooq et al. 2014).”
InfluentialAlbtoosh, A., Karawya, F. S., Al-Naymat, W., & Al-Qaitat, A. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1983330 · Cited by 12
Monitoring of Spirulina Flakes and Powders from Italian Companies
Costa, V. D., Filippini, R., Zusso, M., Caniato, R., & Piovan, A. (2022) · Molecules · doi:10.3390/molecules27103155 · Cited by 10
Landrigan, J., Dwyer, Z., Beauchamp, S., Rodríguez, R., Fortin, T., & Hayley, S. P. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.11.007 · Cited by 9
Sharma, S., Tanwar, S. S., Dwivedi, S., & Khan, S. (2025) · Current Biotechnology · doi:10.2174/0122115501352964250914125955 · Cited by 9
Patil, J., Matte, A., Nissbrandt, H., Mallard, C. E., & Sandberg, M. (2016) · NeuroImmunoModulation · doi:10.1159/000452714 · Cited by 7
DiNicolantonio, J. J., McCarty, M. F., & O’Keefe, J. H. (2019) · Open Heart · doi:10.1136/openhrt-2018-000897 · Cited by 8
Abdullahi, D., Ahmad Annuar, A., & Sanusi, J. (2020) · Ultrastructural Pathology · doi:10.1080/01913123.2020.1792597 · Cited by 5
McCarty, M. F., & Alharbi, S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.003 · Cited by 6
Preventive Role of Cocoa-Enriched Extract Against Neuroinflammation in Mice
Carrera, I., Corzo, L., Martínez-Iglesias, O. A., Naidoo, V., & Cacabelos, R. (2025) · Neurology International · doi:10.3390/neurolint17040047 · Cited by 4
“In particular, it has been demonstrated that phytoconstituents found in spirulina ( Arthrospira maxima ) [27–30] and pineapple ( Ananas comosus ) [31–33] have specific beneficial antioxidant and anti-inflammatory qualities tested both in vitro and in vivo animal models as well as in clinical…”
Bioactive Compounds of the Genus Spirulina Can Prevent the Progression of Neurological Diseases
Elkader, H. A. E. A., Essawy, A. E., & Al‐Shami, A. S. (2024) · Neurochemical Journal · doi:10.1134/s1819712424010057 · Cited by 6
Parkinson’s Disease: An Overview of Etiology, Clinical Manifestations, and Treatment
Dalvi, A., Lyons, K. E., & Pahwa, R. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_1 · Cited by 5
Pentón‐Rol, G., Marín‐Prida, J., Sarduy-Chávez, R. D. L. C., & Hernández-González, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00016-6 · Cited by 3
Stress-resilient effect of Spirulina platensis on zebrafish chronic unpredictable stress model
Kumar, H., Kaur, K., & Kaur, R. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114691 · Cited by 3
The potential of marine-derived compounds in geroscience
Giuliani, M. E., Giordani, C., Bertoni, G., Francini, E., Bigossi, G., Lai, G., Marcozzi, S., Alimi, S. S., Perini, D., Piccinini, A., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102935 · Cited by 3
Antiviral products derived from microalgae
Niccolai, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19213-5.00012-1 · Cited by 2
Kumar, H., Garg, V., Kaur, K., & Kaur, R. (2023) · Annals of Neurosciences · doi:10.1177/09727531231166202 · Cited by 2
Spirulina: A panacea for all human ailments
Pingili, D., Awasthi, A., Maqsood, M., Devi, K. S., Rasagna, P., Bhagoji, S., Amminbavi, D., & Raju, M. B. (2023) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2023.12.1.39 · Cited by 2
Chouala, K., Boudjema, K., Khelef, Y., Nani, S., Ouali, K., Boumendjel, M., Boumendjel, A., & Messarah, M. (2024) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-023-00203-7 · Cited by 2
“Several studies have demonstrated the effectiveness of Spirulina in treating diseases linked to free radicals, inflammation, neurodegenerative disorders [7, 8], diabetes [9, 10], polycystic ovarian syndrome [11], hypertension HTN [12], and cancers [13].”
Spirulina: Morphology, Cultivation, Harvesting as a Supplement and Its Therapeutic Properties
Khushala, A., Bobby, M. N., & Balasubramaniyan, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1844-6_9 · Cited by 3
Issues Regarding Toxicity and Safety of Foods from Seaweeds
Ferrara, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-92174-3_15 · Cited by 2
Therapeutic Potential of Cyanobacteria as a Producer of Novel Bioactive Compounds
Yadav, P., Singh, R. P., Kumar, A., Singh, P. K., & Gupta, R. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0181-4_13 · Cited by 4
The Neuroprotective and Antioxidant Activities of Spirulina
Bertolin, T. E., Guarienti, C., Frota, E. G., & Outeiro, T. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-61253-4_7 · Cited by 3
Neuroprotective and Antioxidant Study of Cyanobacteria Arthrospira
Panda, K. C., Das, R., Kumar, B. V. V. R., & Sruti, J. (2025) · Current Aging Science · doi:10.2174/0118746098365217250828003543 · Cited by 1
Taheri, A. T., Motamedzadeh, A., Zahedi, E., Farasat, A., Dadgostar, E., Aschner, M., Khanifar, H., Rahmati‐Dehkordi, F., & Tamtaji, O. R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12532-0 · Cited by 1
“Spirulina also increased the numbers of Tyrosine hydroxylase (TH) + and NeuN+ cells, and decreased neuronal loss and the numbers of activated microglial cells in AAV-9 α-synuclein model of PD in rats [ 34 ].”
The Glial Perspective of Energy Homeostasis, Neuroinflammation, and Neuro-nutraceuticals
Sinha, S., Patro, N., & Patro, I. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_23 · Cited by 1
Abdullahi, D., Ahmad‐Annuar, A., & Sanusi, J. (2019) · Ultrastructural Pathology · doi:10.1080/01913123.2019.1695693 · Cited by 1
Potential plant extracts in the treatment of Parkinson’s disease
Obulesu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95762-5.00003-5
Al-Maathidy, A., Karawya, F. S., Al-Qaraleh, S. Y., & Al-Qtaitat, A. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2674
Lee, J. Y., Lim, L. W. C., Wong, C.-Y., Koh, R. Y., Lim, C. L., Kok, Y.-Y., & Chye, S. M. (2026) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273403412251202093934 · Cited by 1
Rzeski, W., & Rzeska, W. (2026) · Molecules · doi:10.3390/molecules31101595
“…models provide further support for neuroprotective effects, including the preservation of dopaminergic neurons and reduced neuroinflammation in Parkinson’s disease models, as well as the attenuation of oxidative stress and cognitive decline in experimental models of neurode-generation [61,73,74].”
Girgenti, A., Picone, P., Palumbo, L., Lauceri, R., & Nuzzo, D. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00720-2
“In vivo studies have highlighted the neuroprotective effects of Spirulina against neuroinflammatory insults across brain regions in Parkinson’s disease (PD) models [6].”
Kim, S., & Park, S.-K. (2026) · Rejuvenation Research · doi:10.1177/15491684261460844
Metadata
- Authors
- Pabon, M. M., Jernberg, J. N., Morganti, J., Contreras, J., Hudson, C. E., Klein, R. L., & Bickford, P. C.
- Affiliations
- University of South Florida (US)
- Tulane University (US)
- James A. Haley Veterans' Hospital (US)
- Louisiana State University Health Sciences Center Shreveport (US)
- Corresponding author
- Bickford, Paula C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-18
- Volume
- 7
- Issue
- 9
- Pages
- e45256
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3445455
- OpenAlex
- W2070772378
- Cited by
- 90
- References
- 49
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 2 · 2017: 3 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 3
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Spirulina, Parkinson's disease, alpha-synuclein, microglial activation, neuroprotection, substantia nigra pars compacta, adeno-associated virus vectors, AAV9, tyrosine hydroxylase, MHC class II, CX3CR1, neuroinflammation, dietary supplementation, neurodegeneration
- MeSH terms
- CX3C Chemokine Receptor 1, Dependovirus, Animals, Histocompatibility Antigens Class II, Diet, Disease Models, Animal, Gene Expression Regulation, Injections, Intraventricular, Male, Parkinson Disease, Secondary, Substantia Nigra, Tyrosine 3-Monooxygenase, Microglia, Neuroprotective Agents, Receptors, Chemokine, Rats, alpha-Synuclein, Spirulina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.